
Solo Peptide · Energy & Performance Track
A legacy ghrelin-receptor agonist that triggers strong growth hormone release from the pituitary. Older than Ipamorelin but more potent on a per-dose basis. Physician-prescribed and compounded in the U.S. by a 503A-licensed pharmacy.
Adults who want a more aggressive GH release than Ipamorelin provides and don’t mind a modest hunger response. Typically used by patients with experience in the GH-axis category who know they tolerate the profile and want stronger hormonal signal per dose.
GHRP-2 binds the ghrelin receptor (GHSR) in the pituitary and hypothalamus, triggering growth hormone release plus a mild appetite cue. Compared to Ipamorelin: stronger GH push, slightly less clean — small bumps in cortisol and prolactin come with the territory. Typically stacked with a GHRH like CJC or Sermorelin for full-axis activation.